These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8088736)

  • 1. Case manager ratings of the clinical status of dually diagnosed outpatients.
    Comtois KA; Ries R; Armstrong HE
    Hosp Community Psychiatry; 1994 Jun; 45(6):568-73. PubMed ID: 8088736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent validity of clinicians' ratings of substance abuse among psychiatric outpatients.
    Carey KB; Cocco KM; Simons JS
    Psychiatr Serv; 1996 Aug; 47(8):842-7. PubMed ID: 8837156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptom severity and utilization of treatment resources among dually diagnosed inpatients.
    Ries R; Mullen M; Cox G
    Hosp Community Psychiatry; 1994 Jun; 45(6):562-8. PubMed ID: 8088735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating changes in symptoms and functioning of dually diagnosed clients in specialized treatment.
    Jerrell JM; Ridgely MS
    Psychiatr Serv; 1995 Mar; 46(3):233-8. PubMed ID: 7796208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of alcohol and other drug disorders in the seriously mentally ill.
    Barry KL; Fleming MF; Greenley J; Widlak P; Kropp S; McKee D
    Schizophr Bull; 1995; 21(2):313-21. PubMed ID: 7631177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic limit setting in an assertive community treatment program.
    Neale MS; Rosenheck RA
    Psychiatr Serv; 2000 Apr; 51(4):499-505. PubMed ID: 10737826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of case manager ratings and weekly urine toxicology tests among outpatients with dual diagnoses.
    Ries RK; Dyck DG; Short R; Srebnik D; Snowden M; Comtois KA
    Psychiatr Serv; 2002 Jun; 53(6):764-6. PubMed ID: 12045318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Noordsy DL; Xie H; Drake RE
    Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbid substance abuse and recovery from acute psychiatric relapse.
    Sanguineti VR; Samuel SE
    Hosp Community Psychiatry; 1993 Nov; 44(11):1073-6. PubMed ID: 8288176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conduct disorder and antisocial personality disorder in persons with severe psychiatric and substance use disorders.
    Mueser KT; Crocker AG; Frisman LB; Drake RE; Covell NH; Essock SM
    Schizophr Bull; 2006 Oct; 32(4):626-36. PubMed ID: 16574783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining subgroups of dual diagnosis patients for service planning.
    Lehman AF; Myers CP; Dixon LB; Johnson JL
    Hosp Community Psychiatry; 1994 Jun; 45(6):556-61. PubMed ID: 8088734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Illness Management and Recovery Scale in schizophrenia and schizoaffective disorder.
    Färdig R; Lewander T; Fredriksson A; Melin L
    Schizophr Res; 2011 Nov; 132(2-3):157-64. PubMed ID: 21798718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term course of substance use disorders among patients with severe mental illness.
    Bartels SJ; Drake RE; Wallach MA
    Psychiatr Serv; 1995 Mar; 46(3):248-51. PubMed ID: 7796211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 12-month prospective follow-up study of patients with schizophrenia-spectrum disorders and substance abuse: changes in psychiatric symptoms and substance use.
    Margolese HC; Carlos Negrete J; Tempier R; Gill K
    Schizophr Res; 2006 Mar; 83(1):65-75. PubMed ID: 16460917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of the SCID in substance abuse patients.
    Kranzler HR; Kadden RM; Babor TF; Tennen H; Rounsaville BJ
    Addiction; 1996 Jun; 91(6):859-68. PubMed ID: 8696248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Employment outcomes for clients with severe mental illness in a PACT model replication. Program for Assertive Community Treatment.
    Becker RE; Meisler N; Stormer G; Brondino MJ
    Psychiatr Serv; 1999 Jan; 50(1):104-6. PubMed ID: 9890590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of psychiatric care for dual diagnosis patients treated in a drug dependence clinic.
    Saxon AJ; Calsyn DA
    Am J Drug Alcohol Abuse; 1995 Aug; 21(3):303-13. PubMed ID: 7484981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance use and cognition in early psychosis.
    Pencer A; Addington J
    J Psychiatry Neurosci; 2003 Jan; 28(1):48-54. PubMed ID: 12587850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment satisfaction compared with outcome in severe dual disorders.
    Ries RK; Jaffe C; Comtois KA; Kitchell M
    Community Ment Health J; 1999 Jun; 35(3):213-21. PubMed ID: 10401891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of BPRS-A percent change scores to identify significant clinical improvement: accuracy of treatment response classification in acute psychiatric inpatients.
    Lachar D; Bailley SE; Rhoades HM; Varner RV
    Psychiatry Res; 1999 Dec; 89(3):259-68. PubMed ID: 10708272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.